| 1. |
Aneela Gohar,K.Rauf,U. Rashid,Yasser MSA Alkahraman Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition, Drug Design, Development and Therapy, 2023 |
| 2. |
M. Ashfaq,Yasser MSA Alkahraman,Mobasher,J.Sharif,Khan Q Long-Term Proton Pump Inhibitor Therapy and its Effect on Endocrine Hormones in Selected Patient Population, Hormone and Metabolic Research, 2023 |
| 3. |
M. Ashfaq,Yasser MSA Alkahraman Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders, Endocrine Regulations, 2022 |
| 4. |
Dr. S. Shah,A Ali,Yasser MSA Alkahraman,Asad. M.H.H.B Nano-Porous Zirconia Membranes for Separation of Hydrogen from Carbon Dioxide, Pol. J. Environ. Stud., 2021 |
| 5. |
Yasser MSA Alkahraman Nano-Porous Zirconia Membranes for Separation of Hydrogen from Carbon Dioxide, research paper, 2021 |
| 6. |
Dr. Jamshed Iqbal,Hafiz Saqib Ali,Behzad Jafari,Sumera Zaib,Abdul Hameed,Peter Langer,Yasser MSA Alkahraman,Shafiq Ur Rahman Structure-Based Virtual Screening of Dipeptidyl Peptidase 4 Inhibitors and their In vitro Analysis.", Computational Biology and Chemistry , 2021 |
| 7. |
Yasser MSA Alkahraman,M. Ashfaq,Mobasher,K.Rauf Potential Role of Proton Pump Inhibitors Against Human DRD2 Receptor in Drug Induced Hyperprolactinemia, Revista de Chimie, 2020 |
| 8. |
Asad. M.H.H.B,A Ali,Yasser MSA Alkahraman Malaria, dengue and chikungunya in Pakistan: Recent insights about prevalence, diagnosis and treatment. , Pakistan Journal of Pharmaceutical sciences, 2019 |
| 9. |
A. Mannan,A.Nazir,Dr. Nighat Fatima,Shujaat A.K, SA Khan,Yasser MSA Alkahraman Antioxidants, antimicrobial and cytotoxic potential of Swertia chirata, Biomedical Research, September 01, 2018, 2018 |
| 10. |
Yasser MSA Alkahraman Design, Synthesis, and In Vitro Antileishmanial and Antitumor Activities of New Tetrahydroquinolines, 28.02.2018, 2018 |
| 11. |
Yasser MSA Alkahraman Antimicrobial, Crown Gall Tumor Inhibitory and Cytotoxicity Assays of N-[(1-methyl-1H-indole-3-yl)methylene]amines Synthesized by an Improved Protocol, 20/04/2014, 2014 |
| 12. |
Yasser MSA Alkahraman Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents, 25 June 2012, 2012 |
| 13. |
Yasser MSA Alkahraman Evaluation of Some Classical Hydrazones of Ketones and 1,2-Diketones as Antileishmanial, Antibacterial and Antifungal Agents, December 30, 2011, 2011 |
| 14. |
Yasser MSA Alkahraman Evaluation of N-(2-Thienylidene)amines, N-(2-Hydroxybenzylidene)amines and 3-Iminoindolin-2-ones as Antileishmanial Agents, February/ 23, 2011 |
| 15. |
Yasser MSA Alkahraman Antileishmanial, Antimicrobial and Antifungal Activities of Some New Aryl Azomethines, 28 January 2010, 2010 |
